Figure 1From: Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial) V-shoRT-R3 study design. a) Scheme of phase I study, b) Plan of Phase II study.Back to article page